Tirzepatide
Advanced Support for Weight Loss and Metabolic Health
Tirzepatide is a once-weekly medication used to support weight loss, appetite regulation, and metabolic health.
At Radiant You, it’s used as part of a structured, physician-guided approach designed to help you lose weight in a way that is both effective and sustainable.
Quick Take
- Weekly injection that reduces appetite and improves metabolic function
- Average weight loss ~15–20% in clinical trials
- Targets two key metabolic pathways (GLP-1 and GIP)
- Also improves blood sugar, cardiovascular risk factors, and sleep apnea
- Most effective when combined with a structured, personalized plan
What the Research Shows
Tirzepatide works by activating two natural hormone systems involved in metabolism:
- GLP-1 (glucagon-like peptide-1)
- GIP (glucose-dependent insulinotropic polypeptide)
These hormones help regulate:
- Hunger and satiety
- Blood sugar levels
- How the body processes and stores energy
It is FDA-approved as:
- Mounjaro® – for type 2 diabetes
- Zepbound® – for chronic weight management and obstructive sleep apnea in people with obesity
What Kind of Results Can You Expect?
In large clinical trials, tirzepatide has demonstrated substantial weight loss.
In the SURMOUNT-1 trial:
- Average weight loss ranged from ~15–21% over 72 weeks
- Up to 57% of participants lost 20% or more of their body weight
This level of weight loss approaches what is sometimes seen with surgical interventions. Results vary based on consistency, lifestyle, and individual physiology.
Tirzepatide vs. Semaglutide
Both tirzepatide and semaglutide are effective tools for weight loss and metabolic health.
In clinical trials:
- Semaglutide (STEP-1): ~15% average weight loss
- Tirzepatide (SURMOUNT-1): ~15–21% average weight loss
Tirzepatide has shown greater average weight loss in head-to-head comparisons, though both medications can produce meaningful results.
The right choice depends on your individual goals, medical history, and response to treatment.
Beyond Weight Loss: Metabolic Health Benefits
Tirzepatide has also been shown to improve multiple markers of metabolic health, including:
- Blood sugar control
- Risk of progression from prediabetes to diabetes
- Blood pressure and cholesterol
In the SURMOUNT-OSA trial:
- Sleep apnea events were reduced by ~55–63%
- Average weight loss was ~18–20%
These findings highlight its role in improving overall metabolic function — not just body weight.
Most side effects are digestive and tend to occur early in treatment or with dose increases.
These may include:
- Nausea
- Diarrhea
- Constipation
- Vomiting
Symptoms are typically mild and improve as your body adjusts.
Tirzepatide carries a boxed warning related to thyroid tumors observed in animal studies.
It should not be used in patients with:
- Personal or family history of medullary thyroid cancer
- Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
The relevance of this finding in humans remains unclear.
How This Fits Into Your Health
Tirzepatide helps regulate appetite and metabolism, but the best results occur when it’s combined with the right foundation.
This includes:
- Nutrition
- Strength training and physical activity
- Sleep
- Metabolic and hormonal health
And if those areas aren’t fully where you want them to be, that’s exactly where we can help — through a more comprehensive, personalized approach to your health at Radiant You.
How We Approach Weight Loss at Radiant You
At Radiant You, tirzepatide is one part of a broader, personalized strategy focused on long-term success.
Our approach emphasizes:
- Improving metabolic health
- Preserving lean muscle during weight loss
- Building sustainable nutrition and lifestyle habits
- Supporting long-term weight maintenance
This is not just about losing weight — it’s about improving how your body functions and helping you keep the results.
Our Approach to Care
We prioritize treatments that are grounded in physiology, supported by strong clinical evidence, and used with clear expectations.
Tirzepatide is a powerful tool — but it works best when used intentionally, with the right structure and support.
Our role is to guide that process with you so your results are both effective and sustainable.
Sources & Further Reading
For those interested in the research behind tirzepatide, here are some of the key studies that inform our approach:
Weight Loss (SURMOUNT Trials)
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
Comparison to Semaglutide
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
Sleep Apnea and Metabolic Outcomes
- SURMOUNT-OSA Trial. Tirzepatide for Obstructive Sleep Apnea in Adults with Obesity. New England Journal of Medicine. 2024.